Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment
CEO & Founder Conversations
•
30m
The pharmaceutical industry is experiencing extraordinary innovation, fueled by breakthroughs in science, technology, and data analytics. Novartis (NYSE: NVS) stands as a driving force in this wave of transformation. From gene and cell therapies to targeted cancer treatments and immunology, Novartis consistently delivers solutions for some of the most complex health problems. CEO Vas Narasimhan goes Inside the ICE House to discuss the significant success achieved and how the company, under his leadership, sharpened its focus on innovative medicines to combat some of the world's most pressing medical challenges.
Up Next in CEO & Founder Conversations
-
The Hartford's Chris Swift & Claire B...
For 215 years, the Hartford Insurance Group (NYSE: HIG) has been a steadfast force in helping customers and communities recover from devastation. Since 1810, the insurance industry icon has remained committed to supporting those it serves through both hardships and victories. CEO & Chairman Chris...
-
Riskified's Agi Dotcheva on Partnersh...
E-commerce fraud is surging, putting businesses and consumers at risk in an increasingly digital world. From stolen credit cards to account takeovers, cybercriminals drain billions from companies and leave customers vulnerable. Riskified (NYSE: RSKD) is fighting back, using cutting-edge technolog...
-
Flock Safety CEO Garrett Langley on R...
Law enforcement technology is evolving fast, transforming how agencies prevent and tackle crime. With cutting-edge tools like license plate recognition, gunshot detection, and drone-first responders, officers now have real-time intelligence at their fingertips. Leading the charge is Flock Safety,...
